%D8%AF%D9%8A%D9%84%D8%A7%D9%81%D9%8A%D8%B1%D8%AF%D9%8A%D9%86Category:DelavirdineDelafirdinDelavirdinDelavirdineDelavirdineDelavirdinaDelavirdinDelavirdin%E0%B8%94%E0%B8%B5%E0%B8%A5%E0%B8%B2%E0%B9%80%E0%B8%A7%E0%B8%B5%E0%B8%A2%E0%B8%A3%E0%B9%8C%E0%B8%94%E0%B8%B5%E0%B8%99%D0%94%D0%B5%D0%BB%D0%B0%D0%B2%D1%96%D1%80%D0%B4%D0%B8%D0%BDDelavirdineQ370244
about
P3781
Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors.Delavirdine: clinical pharmacokinetics and drug interactions.Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinations.Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine.Delavirdine levels in womenDelavirdine gets FDA approval. Food and Drug AdministrationDelavirdine data: skewed or skewered?FDA advisory committee deadlocks on delavirdine. Food and Drug AdministrationDelavirdine expanded access programNevirapine and delavirdine plus protease inhibitorsA computational study of CYP3A4 mediated drug interaction profiles for anti-HIV drugs
P921
Q31734304-DBB93553-2841-4B5B-8110-0ADDA6605F8BQ32064655-ADB05166-73B7-4618-9926-6AB7F11FA269Q34235333-EE840D5D-1D11-4726-9ED1-B85E79118A5CQ34394720-3A9A1903-7C7D-4BD1-9844-0BB60623A4B1Q39522504-0DA26C1C-7BB8-4DA7-830B-367589B228EDQ44718125-D0E0C1C9-1875-4C76-BE2B-260F32BAB07BQ44916978-C9679278-7FAB-4F8F-BAAD-BDB0A2EA8B08Q56963871-0C7A8C9E-DC1F-4029-AE48-2BF41CE7BEB4Q56964156-CAE50DC7-C16A-4595-8496-F0146663B456Q56965645-98B6CC46-B0B5-4902-BB69-C273C7738406Q56966113-6B65F6C7-98DB-4AEC-B263-4FDFA832FD20Q56968349-F45DE931-2A1D-4BCC-B507-9100345B3A21Q56969288-031B278B-0EED-4593-938C-AE15A07C3D68Q82466696-10F108DD-1A79-454E-A9C8-5DBB1FBEC5B5
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Delavirdin
@de
Delavirdin
@sh
Delavirdin
@sr
Delavirdine
@nl
Delavirdine
@vi
delafirdin
@cy
delavirdin
@nn
delavirdina
@ca
delavirdina
@pt
delavirdine
@en
type
label
Delavirdin
@de
Delavirdin
@sh
Delavirdin
@sr
Delavirdine
@nl
Delavirdine
@vi
delafirdin
@cy
delavirdin
@nn
delavirdina
@ca
delavirdina
@pt
delavirdine
@en
altLabel
(N-[2-[4-[3-(1-Methylethylamin ...... ndol-5-yl] methanesulfonamide)
@en
1-(3-((1-Methylethyl)amino)-2- ...... indol-2-yl)carbonyl)piperazine
@cy
1-(3-((1-Methylethyl)amino)-2- ...... indol-2-yl)carbonyl)piperazine
@en
2-(4-(5-Methanesulfonamido-1H- ...... (1-methylethyl)-3-pyridinamine
@cy
2-(4-(5-Methanesulfonamido-1H- ...... (1-methylethyl)-3-pyridinamine
@en
Delavirdin
@cy
Delavirdin
@en
Delavirdina
@cy
Delavirdina
@en
Delavirdine
@cy
prefLabel
Delavirdin
@de
Delavirdin
@sh
Delavirdin
@sr
Delavirdine
@nl
Delavirdine
@vi
delafirdin
@cy
delavirdin
@nn
delavirdina
@ca
delavirdina
@pt
delavirdine
@en